Insights On Outsourced Drug Development

  1. Automated Testing For Compound Toxicity Effects 3/17/2025

    Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.

  2. Reproducibility Study Of A High-Throughput Released N-Glycan Workflow 8/9/2023

    This fast glycan labeling and analysis kit demonstrated that it could yield 576 data points from 2 instruments, 2 cartridges and 3 chemistry kits during inter- and intracapillary reproducibility validation.

  3. AI-Powered Digital Pathology For Pulmonary Fibrosis Biomarker Quantification 3/27/2025

    Uncover how AI-driven digital pathology is revolutionizing the detection and quantification of pulmonary fibrosis markers in whole lung sections, offering new opportunities for clinical research.

  4. Planning for Success: Supply Resiliency Strategies for Bench to Production 10/18/2023

    Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.

  5. Using Affinity Chromatography For The Purification Of Lentiviral Particles 3/11/2024

    This new affinity chromatography resin offers an efficient and scalable purification method for lentiviral particles in combination with gentle elution conditions to retain viral infectivity.

  6. Modified Release Formulations: Extending Drug Commercial Lifecycle 3/1/2024

    A CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.

  7. 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay 9/18/2024

    Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

  8. Functional Characterization Of 3D Assembled Neurospheres 4/4/2025

    Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.

  9. A New Framework For Identifying Nitrosamine Risks And Derisking Products 6/18/2024

    Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

  10. Combining Single-Cell Isolation And Microplate Imaging To Improve Cloning Efficiency 8/21/2023

    Improve your cloning efficiency with higher assurance of clonality by using a combination of single-cell isolation and microplate imaging.